Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of hematology, the Italian Society of Experimental hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up

Ercole Brusamolino, Andrea Bacigalupo, Giovanni Barosi, Giampaolo Biti, Paolo G. Gobbi, Alessandro Levis, Monia Marchetti, Armando Santoro, Pier Luigi Zinzani, Sante Tura

Research output: Contribution to journalArticle

Abstract

The Italian Society of Hematology (SIE), the Italian Society of Experimental Haematology (SIES) and the Italian Group for Bone Marrow Transplantation (GITMO) commissioned a project to develop practice guidelines for the initial work-up, therapy and follow-up of classical Hodgkin's lymphoma. Key questions to the clinical evaluation and treatment of this disease were formulated by an Advisory Committee, discussed and approved by an Expert Panel (EP) composed of senior hematologists and one radiotherapist. After a comprehensive and systematic literature review, the EP recommendations were graded according to their supporting evidence. An explicit approach to consensus methodologies was used for evidence interpretation and for producing recommendations in the absence of a strong evidence. The EP decided that the target domain of the guidelines should include only classical Hodgkin's lymphoma, as defined by the WHO classification, and exclude lymphocyte predominant histology. Distinct recommendations were produced for initial work-up, first-line therapy of early and advanced stage disease, monitoring procedures and salvage therapy, including hemopoiet-ic stem cell transplant. Separate recommendations were formulated for elderly patients. Pre-treatment volumetric CT scan of the neck, thorax, abdomen, and pelvis is mandatory, while FDG-PET is recommended. As to the therapy of early stage disease, a combined modality approach is still recommended with ABVD followed by involved-field radiotherapy; the number of courses of ABVD will depend on the patient risk category (favorable or unfavorable). Full-term chemotherapy with ABVD is recommended in advanced stage disease; adjuvant radiotherapy in patients without initial bulk who achieved a complete remission is not recommended. In the elderly, chemotherapy regimens more intensive than ABVD are not recommended. Early evaluation of response with FDG-PET scan is suggested. Relapsed or refractory patients should receive high-dose chemotherapy and autologous hemopoietic stem cells transplant. Allogeneic transplant is recommended in patients relapsing after autologous transplant. All fertile patients should be informed of the possible effects of therapy on gonadal function and fertility preservation measures should be taken before the initiation of therapy.

Original languageEnglish
Pages (from-to)550-565
Number of pages16
JournalHaematologica
Volume94
Issue number4
DOIs
Publication statusPublished - Apr 2009

Fingerprint

Hematology
Bone Marrow Transplantation
Hodgkin Disease
Guidelines
Transplants
Drug Therapy
Therapeutics
Stem Cells
Fertility Preservation
Salvage Therapy
Adjuvant Radiotherapy
Cone-Beam Computed Tomography
Autografts
Advisory Committees
Pelvis
Practice Guidelines
Positron-Emission Tomography
Abdomen
Histology
Neck

Keywords

  • Clinical guidelines
  • Hodgkin's lymphoma

ASJC Scopus subject areas

  • Hematology

Cite this

Classical Hodgkin's lymphoma in adults : guidelines of the Italian Society of hematology, the Italian Society of Experimental hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up. / Brusamolino, Ercole; Bacigalupo, Andrea; Barosi, Giovanni; Biti, Giampaolo; Gobbi, Paolo G.; Levis, Alessandro; Marchetti, Monia; Santoro, Armando; Zinzani, Pier Luigi; Tura, Sante.

In: Haematologica, Vol. 94, No. 4, 04.2009, p. 550-565.

Research output: Contribution to journalArticle

Brusamolino, Ercole ; Bacigalupo, Andrea ; Barosi, Giovanni ; Biti, Giampaolo ; Gobbi, Paolo G. ; Levis, Alessandro ; Marchetti, Monia ; Santoro, Armando ; Zinzani, Pier Luigi ; Tura, Sante. / Classical Hodgkin's lymphoma in adults : guidelines of the Italian Society of hematology, the Italian Society of Experimental hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up. In: Haematologica. 2009 ; Vol. 94, No. 4. pp. 550-565.
@article{e697a407cc1b46ccad0057d2ae1f42ea,
title = "Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of hematology, the Italian Society of Experimental hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up",
abstract = "The Italian Society of Hematology (SIE), the Italian Society of Experimental Haematology (SIES) and the Italian Group for Bone Marrow Transplantation (GITMO) commissioned a project to develop practice guidelines for the initial work-up, therapy and follow-up of classical Hodgkin's lymphoma. Key questions to the clinical evaluation and treatment of this disease were formulated by an Advisory Committee, discussed and approved by an Expert Panel (EP) composed of senior hematologists and one radiotherapist. After a comprehensive and systematic literature review, the EP recommendations were graded according to their supporting evidence. An explicit approach to consensus methodologies was used for evidence interpretation and for producing recommendations in the absence of a strong evidence. The EP decided that the target domain of the guidelines should include only classical Hodgkin's lymphoma, as defined by the WHO classification, and exclude lymphocyte predominant histology. Distinct recommendations were produced for initial work-up, first-line therapy of early and advanced stage disease, monitoring procedures and salvage therapy, including hemopoiet-ic stem cell transplant. Separate recommendations were formulated for elderly patients. Pre-treatment volumetric CT scan of the neck, thorax, abdomen, and pelvis is mandatory, while FDG-PET is recommended. As to the therapy of early stage disease, a combined modality approach is still recommended with ABVD followed by involved-field radiotherapy; the number of courses of ABVD will depend on the patient risk category (favorable or unfavorable). Full-term chemotherapy with ABVD is recommended in advanced stage disease; adjuvant radiotherapy in patients without initial bulk who achieved a complete remission is not recommended. In the elderly, chemotherapy regimens more intensive than ABVD are not recommended. Early evaluation of response with FDG-PET scan is suggested. Relapsed or refractory patients should receive high-dose chemotherapy and autologous hemopoietic stem cells transplant. Allogeneic transplant is recommended in patients relapsing after autologous transplant. All fertile patients should be informed of the possible effects of therapy on gonadal function and fertility preservation measures should be taken before the initiation of therapy.",
keywords = "Clinical guidelines, Hodgkin's lymphoma",
author = "Ercole Brusamolino and Andrea Bacigalupo and Giovanni Barosi and Giampaolo Biti and Gobbi, {Paolo G.} and Alessandro Levis and Monia Marchetti and Armando Santoro and Zinzani, {Pier Luigi} and Sante Tura",
year = "2009",
month = "4",
doi = "10.3324/haematol.2008.002451",
language = "English",
volume = "94",
pages = "550--565",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "4",

}

TY - JOUR

T1 - Classical Hodgkin's lymphoma in adults

T2 - guidelines of the Italian Society of hematology, the Italian Society of Experimental hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up

AU - Brusamolino, Ercole

AU - Bacigalupo, Andrea

AU - Barosi, Giovanni

AU - Biti, Giampaolo

AU - Gobbi, Paolo G.

AU - Levis, Alessandro

AU - Marchetti, Monia

AU - Santoro, Armando

AU - Zinzani, Pier Luigi

AU - Tura, Sante

PY - 2009/4

Y1 - 2009/4

N2 - The Italian Society of Hematology (SIE), the Italian Society of Experimental Haematology (SIES) and the Italian Group for Bone Marrow Transplantation (GITMO) commissioned a project to develop practice guidelines for the initial work-up, therapy and follow-up of classical Hodgkin's lymphoma. Key questions to the clinical evaluation and treatment of this disease were formulated by an Advisory Committee, discussed and approved by an Expert Panel (EP) composed of senior hematologists and one radiotherapist. After a comprehensive and systematic literature review, the EP recommendations were graded according to their supporting evidence. An explicit approach to consensus methodologies was used for evidence interpretation and for producing recommendations in the absence of a strong evidence. The EP decided that the target domain of the guidelines should include only classical Hodgkin's lymphoma, as defined by the WHO classification, and exclude lymphocyte predominant histology. Distinct recommendations were produced for initial work-up, first-line therapy of early and advanced stage disease, monitoring procedures and salvage therapy, including hemopoiet-ic stem cell transplant. Separate recommendations were formulated for elderly patients. Pre-treatment volumetric CT scan of the neck, thorax, abdomen, and pelvis is mandatory, while FDG-PET is recommended. As to the therapy of early stage disease, a combined modality approach is still recommended with ABVD followed by involved-field radiotherapy; the number of courses of ABVD will depend on the patient risk category (favorable or unfavorable). Full-term chemotherapy with ABVD is recommended in advanced stage disease; adjuvant radiotherapy in patients without initial bulk who achieved a complete remission is not recommended. In the elderly, chemotherapy regimens more intensive than ABVD are not recommended. Early evaluation of response with FDG-PET scan is suggested. Relapsed or refractory patients should receive high-dose chemotherapy and autologous hemopoietic stem cells transplant. Allogeneic transplant is recommended in patients relapsing after autologous transplant. All fertile patients should be informed of the possible effects of therapy on gonadal function and fertility preservation measures should be taken before the initiation of therapy.

AB - The Italian Society of Hematology (SIE), the Italian Society of Experimental Haematology (SIES) and the Italian Group for Bone Marrow Transplantation (GITMO) commissioned a project to develop practice guidelines for the initial work-up, therapy and follow-up of classical Hodgkin's lymphoma. Key questions to the clinical evaluation and treatment of this disease were formulated by an Advisory Committee, discussed and approved by an Expert Panel (EP) composed of senior hematologists and one radiotherapist. After a comprehensive and systematic literature review, the EP recommendations were graded according to their supporting evidence. An explicit approach to consensus methodologies was used for evidence interpretation and for producing recommendations in the absence of a strong evidence. The EP decided that the target domain of the guidelines should include only classical Hodgkin's lymphoma, as defined by the WHO classification, and exclude lymphocyte predominant histology. Distinct recommendations were produced for initial work-up, first-line therapy of early and advanced stage disease, monitoring procedures and salvage therapy, including hemopoiet-ic stem cell transplant. Separate recommendations were formulated for elderly patients. Pre-treatment volumetric CT scan of the neck, thorax, abdomen, and pelvis is mandatory, while FDG-PET is recommended. As to the therapy of early stage disease, a combined modality approach is still recommended with ABVD followed by involved-field radiotherapy; the number of courses of ABVD will depend on the patient risk category (favorable or unfavorable). Full-term chemotherapy with ABVD is recommended in advanced stage disease; adjuvant radiotherapy in patients without initial bulk who achieved a complete remission is not recommended. In the elderly, chemotherapy regimens more intensive than ABVD are not recommended. Early evaluation of response with FDG-PET scan is suggested. Relapsed or refractory patients should receive high-dose chemotherapy and autologous hemopoietic stem cells transplant. Allogeneic transplant is recommended in patients relapsing after autologous transplant. All fertile patients should be informed of the possible effects of therapy on gonadal function and fertility preservation measures should be taken before the initiation of therapy.

KW - Clinical guidelines

KW - Hodgkin's lymphoma

UR - http://www.scopus.com/inward/record.url?scp=66349130191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66349130191&partnerID=8YFLogxK

U2 - 10.3324/haematol.2008.002451

DO - 10.3324/haematol.2008.002451

M3 - Article

C2 - 19278966

AN - SCOPUS:66349130191

VL - 94

SP - 550

EP - 565

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 4

ER -